Recall Z-0008-2009 ยท JFY Enzymatic Method, Creatinine
Roche Diagnostics Corp.
Roche Diagnostics CREP2, Creatinine Plus Ver. 2, COBAS INTEGRA, cobas c systems, Roche Diagnostics, Indianapolis, IN.; 03263991190. An in-vitro diagnostic reagent system intended for use on COBAS Integra systems for the quantitative determination of creatine in serum, urine and plasma.
| Date | Oct 9, 2008 (initiated Jun 11, 2008) |
| Status | Terminated |
| Reason | Some of the labels are glossy, resulting in the bar code being difficult to read by the bar code reader. |
| Root cause | Labeling Change Control |
| Action | Consignees were notified via an Urgent Medical Device correction letter dated 6/11/08 informing users of the problem and providing them with work-around instructions. The instructions suggests 1) inserting the cassette rack slowly; 2) using mainly reagent slots A, B, or C; 3) tilting the rack slightly clockwise so the barcode scanner does not read the barcode at an exact 90 degree angle; and 4) confirming the rack is properly seated on the track and displayed on the Cassette Status screen. If the cassette barcode does not register after following the Work-Around instructions, then customers |
| Quantity | 1068 |
| Distribution | Nationwide Distribution |
| FDA record | Open on fda.gov |
510(k) clearances named in this recall
| K024098 | COBAS INTEGRA CREATININE PLUS VER.2 ASSAY Roche Diagnostics Corp., Dec 19, 2002 |